OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
RDGL
Vivos Inc.
Common Stock
0.11
-0.0039
-3.42%
No Inside Bid / Offer
Real-Time Best Bid & Ask: 07:06am 07/11/2025
Delayed (15 Min) Trade Data: 12:00am 07/10/2025
0.1139
0.1068 - 0.1188
261,659
Market Cap calculated only for this class of securities.
50,213,413
Real-Time Level 2 Quote
Trade Data
News
Filings and Disclosure
Company Description
Vivos Inc developed a Y-90 brachytherapy product called Precision Radionuclide TherapyTM. It is designated as "Breakthrough" by the FDA. There is an ongoing clinical trial in humans in India and multiply animal therapies for horses, dogs, cats, and exotics in a growing number of certified clinics across the United States.
Videos
Loading...
Symbol
OTCM
Last
57.00
Change
-2.25 (-3.80%)
Bid
51.50
Ask
60.25
Volume
2963
Time
00:00
